REG - SEEEN PLC - Total Voting Rights

SEEENAnnouncement

31/07/2024 17:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240731:nRSe6196Ya&default-theme=true

RNS Number : 6196Y  SEEEN PLC  31 July 2024

31 July 2024

 

SEEEN plc

("SEEEN", the "Group" or the "Company")

 

Total Voting Rights

 

SEEEN plc (AIM: SEEN), the global media and technology platform that delivers
Key Video Moments to drive Video Commerce and transform its clients' video
profitability, announces that, as at today's date, the total number of
ordinary shares of 0.1p each in issue and voting rights in the Company is
120,279,141. This figure of 120,279,141 may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company pursuant to the FCA's Disclosure Guidance and
Transparency Rules.

 

 

For further information please contact:

 SEEEN plc                                                             Tel: +44 (0)7775 701 838
 Adrian Hargrave, Chief Executive Officer

 Dowgate Capital Limited - Joint Broker                                Tel: +44 (0)20 3903 7715
 Stephen Norcross

 Capital Plus Partners Limited - Joint Broker                          Tel: +44 (0)20 3821 6167
 Jonathan Critchley / Jon Levinson

 Allenby Capital Limited - Nominated Adviser and Joint Broker          Tel: +44 (0)20 3328 5656
 Alex Brearley / George Payne / Lauren Wright (Corporate Finance)
 Tony Quirke / Amrit Nahal (Sales and Corporate Broking)

 focusIR - Investor Relations                                          Tel: +44 (0)20 4570 2234
 Paul Cornelius / Kat Perez                                            email: seeen@focusir.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRWPUWGMUPCGGG